Edgen Stock·Oct 14 2025, 05:06Back
Back
FDA Approves Expanded Use for Teva's Uzedy in Bipolar I Disorder, Bolstering Growth Strategy
Edgen Stock·Oct 14 2025, 05:06
[1] TEVA Gets FDA Nod for Uzedy Label Expansion in Bipolar I Disorder (https://finance.yahoo.com/news/teva-gets-fda- ...)[2] Teva's Uzedy Expansion into Bipolar I Disorder: A Catalyst for Market Access and Revenue Growth in Psychiatric Therapeutics - AInvest (https://vertexaisearch.cloud.google.com/groun ...)[3] TEVA Gets FDA Nod for Uzedy Label Expansion in Bipolar I Disorder - TradingView (https://vertexaisearch.cloud.google.com/groun ...)